These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4370285)

  • 1. Primary type V hyperlipoproteinaemia (mixed hyperlipaemia): successful response to dietary restriction and simfibrate.
    Teoh PC; Ransome GA
    Singapore Med J; 1974 Jun; 15(2):149-52. PubMed ID: 4370285
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of type IV and V hyperlipemia--personal experiences].
    Sznajderman M
    Pol Arch Med Wewn; 1978 Feb; 59(2):161-9. PubMed ID: 205844
    [No Abstract]   [Full Text] [Related]  

  • 4. Type V hyperlipoproteinaemia: a family study.
    Raleigh J; Reddy J; Friedlander D; Hope R
    N Z Med J; 1975 Nov; 82(551):300-1. PubMed ID: 174035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fat restrictions and atromid therapy in patients with type II familial hyperlipoproteinemia.
    Sanbar SS; Zweifler AJ; Conway J
    Mich Med; 1968 Nov; 67(21):1346-7. PubMed ID: 5699513
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hyperlipidemias.
    Strisower EH; Adamson G; Strisower B
    Am J Med; 1968 Oct; 45(4):488-501. PubMed ID: 5678093
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofibrate in the management of a case of lipoid dermato-arthritis: a clinical and metabolic study.
    Golding DN
    Ann Rheum Dis; 1968 Sep; 27(5):475-6. PubMed ID: 5677165
    [No Abstract]   [Full Text] [Related]  

  • 9. Type I hyperlipoproteinaemia.
    Brown WV; Greten H
    Clin Endocrinol Metab; 1973 Mar; 2(1):73-80. PubMed ID: 4359118
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperlipaemia in experimental nephrosis and its control by chlorophenoxyisobutyrate and betabenzalbutyrate.
    Edwards KD; Paoletti R
    Med J Aust; 1970 Mar; 1(10):474-7. PubMed ID: 5440989
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipidemias: occurrence, significance, therapy].
    Knüchel F
    Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
    [No Abstract]   [Full Text] [Related]  

  • 12. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

  • 14. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic study of hyperlipoproteinaemia types IV and V.
    François J; Lentini F; Hoste P; Rottiers R
    Clin Genet; 1977 Oct; 12(4):202-7. PubMed ID: 199387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
    Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
    Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis].
    Baranova LV
    Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932
    [No Abstract]   [Full Text] [Related]  

  • 18. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF
    Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H
    Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.